LY2955303
LY2955303 is a potent and selective retinoic acid receptor gamma (RARγ) antagonist with a Ki of 1.09 nM.
Product Specifications
CAS Number
1433497-19-8
UNSPSC
12352005
Hazard Statement
H319, H332, H373
Target
Autophagy; RAR/RXR
Type
Reference compound
Related Pathways
Autophagy; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/LY2955303.html
Concentration
10mM
Purity
99.80
Solubility
DMSO : 30 mg/mL (ultrasonic; warming)
Smiles
CC(C)(C1=CC(C(C)(C)C)=CC(C2=CC(C3=CC=C(C(O)=O)C=C3)=NN2C4=CC=C(C(N5CCN(C)CC5)=O)C=C4)=C1)C
Molecular Formula
C36H42N4O3
Molecular Weight
578.74
Precautions
H319, H332, H373
References & Citations
[1]Hughes NE, et al. Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design. Bioorg Med Chem Lett. 2016 Jul 15;26 (14) :3274-3277.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1237271 0.1 mg
Vedolizumab (ITGA4_ITGB7) - Research Grade Biosimilar Antibody
Sign In for Pricing
View Details 